Breast Augmentation (Implants) | Preparation Before Breast Augmentation

Tests are chosen to check your general health and breast safety before surgery. Blood work may include full blood count, urea and electrolytes, liver function, clotting, glucose and infection screening such as HIV, hepatitis B and C. Urinalysis, ECG and chest X-ray may also be used. Breast examination is essential; if a mass is found, biopsy is needed. Mammography or ultrasound helps assess breast tissue, and mammography is especially recommended if you have personal or family breast cancer risk factors or are over 25. Your surgeon may add tests based on your history, medications or age, and abnormal results may delay surgery until clarified.

Preoperative evaluation includes your history, breast examination and imaging to exclude problems not found on examination. One source recommends mammography for patients over 25 or with risk factors, while another notes ultrasound may suffice for younger breasts and mammography is necessary for older women. Preoperative tests may include mammography and/or breast ultrasound. Imaging also helps assess breast tissue and, after surgery, implants. The exact choice depends on your age, breast density, symptoms, family history, clinical findings and whether implants are already present. No single imaging test is mandated for every patient, and results may delay surgery if an abnormality needs clarification before breast augmentation.

Guidance differs: some sources say routine mammograms before breast surgery should be avoided, with annual screening by age group and extra imaging only for concerning history or examination findings. Other sources recommend a mammogram for anyone over 25 when no risk factors are present, or for patients over 40 or with personal or family breast cancer history. One source requires a mammogram or breast MRI before surgery unless a mastectomy has been performed. A careful breast and axillary examination is also performed, and any mass needs biopsy before proceeding. Your surgeon will decide based on your individual risk profile and examination. This helps ensure any suspicious area is evaluated first.

MRI is an evolving tool for measuring breast volume asymmetry and can assess other breast or chest abnormalities. It is also a sensitive preoperative screening test for breast cancer and can show whether enough fat exists for lipofilling. Mammography is also commonly used, especially with personal or family breast-cancer risk, or for patients over 25 when no risk factors are present; suspicious findings should be clarified before surgery. MRI is more reliable than mammography or ultrasound after prior implantation, but it is expensive and not always available, so it is often reserved for specific doubts. Your surgeon may also request standard preoperative clearance tests and review your medications.

Sources describe a complete medical evaluation before surgery. Breast-specific screening starts with history and family history, then a full breast examination for masses or lymph node enlargement. Mammography is highly recommended with personal or family breast cancer history; one source notes many surgeons obtain it for anyone over 25 when no risk factors exist. Bloodwork may check infection, anemia, clotting and liver function. Pregnancy testing is performed or repeated on surgery day. These steps help identify concerns that could delay augmentation until clarified. Your surgeon also documents weight stability, medications, allergies and prior breast biopsies, because these details affect implant planning and safety. A suspicious mammogram finding is usually clarified before surgery.

A preoperative breast examination looks for masses, asymmetry, nipple changes and other concerns. If a mass is found, biopsy may be needed before surgery. Mammography is used liberally; it is highly recommended with personal or family breast cancer history, and many surgeons reasonably obtain it for patients over 25 when no risk factors are present. Suspicious mammographic findings should be proven benign before augmentation. Examination includes thorough palpation of the breast and armpit while you lie down with your arm raised. A complete medical evaluation, including pregnancy testing on surgery day and blood tests, also helps reduce risk. Implant placement and incision are then chosen from measurements and your anatomy.

Breast augmentation is major surgery, and the process includes a full history and physical examination. The history may include family history of breast cancer, previous breast biopsies, nipple discharge, and recent breast changes. The examination looks for masses, scars, nipple position, chest shape and asymmetry. A lump or other finding may change timing, require further assessment, or affect whether augmentation is appropriate. Implant choice should be tissue-based, and risks should be discussed with your surgeon. Fat transfer may suit only some patients and often needs more than one procedure. Your surgeon will also explain limitations and expected outcomes. A consultation with your surgeon helps decide the safest next step for you now.

Family history is an important part of breast evaluation because a first-degree relative with breast cancer roughly doubles risk, and two first-degree relatives increase it about fivefold. Strong family history, especially with ovarian cancer, may indicate a BRCA gene change and require genetic testing. In such situations, prophylactic mastectomy and reconstruction may be more appropriate than augmentation, because mastectomy could become a lifesaving long-term requirement. A thorough breast and family history, including cancer history, is taken before surgery. Careful consideration should also be given to expectations and body image. If breast cancer is later diagnosed after augmentation, an implant likely does not delay diagnosis, worsen stage at presentation, or reduce survival.

Fibrocystic mastopathy means breast tissue changes that are usually benign, yet they still deserve careful assessment. In this situation, placing the implant in the submuscular layer is preferred, mainly to facilitate diagnostic investigations, including fine-needle aspiration. Women with implants often pay more attention to prevention because surgeons urge regular follow-up. Your surgeon evaluates the most appropriate implant placement for your anatomy and preferences. Implants can be placed behind breast tissue, behind the pectoral muscle, or at the subfascial level depending on each patient. Breast augmentation remains major surgery with potential risks, and the result you hope for cannot be guaranteed.

Breast cysts are usually harmless. With fibrocystic changes, the implant is best placed under the muscle to make diagnosis easier, including needle drainage if needed. After age 40–45, cysts need regular check-ups; after augmentation these may use ultrasound or mammography with special techniques. Implant position is chosen individually based on your breast shape and preferences, and the surgeon assesses the best method during consultation. A thorough breast history and exam, including prior imaging and any concerning symptoms, help plan safe surgery. Women with implants often pay more attention to prevention because surgeons encourage regular follow-up and imaging. This does not mean every cyst needs treatment before surgery. Your surgeon will also review any prior mammograms or ultrasound reports before planning.

Reported concerns include wound breakdown, skin or nipple necrosis, infection, increased capsule formation, thinner dermis, greater implant palpability or exposure, and faster ptosis. Sudden cessation only days before surgery may increase mucous production and raise atelectasis or pneumonia risk, so timing matters. One source on breast surgery after massive weight loss instructs active tobacco users to stop for one month before and after surgery and screens with a urine cotinine test; that timeline is not confirmed here for breast augmentation. One source also notes active tobacco use as an absolute contraindication in some breast surgery contexts, so your surgeon's assessment matters. These are general source-supported considerations, not a personal plan. Preparation and timing should be individualized during consultation.

Blood thinners, aspirin, ibuprofen or naproxen can increase bleeding and bruising, so your surgeon may ask you to stop certain medicines, but chronic medicines should usually continue unless your doctors advise otherwise. One breast augmentation patient form says aspirin-containing drugs should be avoided for at least 10 days before and after surgery. Anticoagulants should be stopped only after discussion with the prescribing physician, at least 5 days before surgery, with INR checked beforehand. Birth control pills or estrogen hormone therapy are stopped 4 weeks before to 2 weeks after surgery, and herbal supplements 2 to 3 weeks before. Herbal remedies may also be stopped as a precaution.

Blood thinners such as aspirin and some anti-inflammatory drugs, vitamin E, fish oil, and herbal or homeopathic remedies may affect clotting and are usually stopped before surgery. Long-term steroids may be a concern and need specialist agreement; birth control pills and some diet pills may also be stopped because they can affect breast size, engorgement, clotting, or heart rhythm. St John’s wort can destabilise blood pressure during anesthesia. Some herbal supplements are stopped two to three weeks before surgery and resumed about two weeks after. Timing is individualised. Always tell your surgeon about every product you take, because interactions and bleeding risks vary by person and by dose. Do not stop prescribed medicines without advice.

Preparation may include blood tests, medication review, smoking cessation and avoiding aspirin or anti-inflammatory drugs that increase bleeding. The estrogen guidance in the sources concerns gender-affirming breast augmentation, not ordinary contraceptive pills or other hormonal contraception: hormone therapy is not a prerequisite, though many surgeons recommend at least 12 months to optimize results; estrogen can contribute to venous thromboembolism risk, and one source advises stopping estrogen two weeks before surgery and resuming two to four weeks after, though this is controversial. Your surgeon should review personal or family clotting history. Do not stop prescribed hormones without medical advice. This is general information, not a personal diagnosis.

Older advice of 10–16 hours of complete fasting is now considered unnecessary by many anesthesiologists. Newer evidence suggests gastric volume may be lower two hours after a small clear liquid intake than after prolonged fasting, and prolonged fasting may increase hypoglycemia risk. Clear liquids such as coffee without cream or pulp-free juice may be allowed up to two hours before surgery; solid food should be avoided for at least eight hours, or ten to twelve hours in some guidance. Milk or a light meal needs at least six hours, and fried or fatty food eight hours. Your surgeon and anesthesiologist should confirm the exact plan.

Breast augmentation restores volume or increases size with implants or fat transfer. Implants may be placed behind breast tissue or muscle, and the same implant can look different in different people. Fat transfer needs stable weight and donor fat, and after fat transfer weight gain or loss changes breast volume. After massive weight loss, stable goal weight for 3-6 months is generally advised before plastic surgery. For gross obesity, losing weight before aesthetic breast surgery is advised because operative risk and complications increase. A cooling-off period and second consultation may be offered. Implant placement and size are individualized after examination, measurements, and discussion of realistic expectations with your surgeon.

Obese patients, at least 40% above normal weight, face higher risk in aesthetic breast surgery: healing, circulation and scarring problems increase, results are harder to achieve, and multiple revisions may be needed. Thick chest and abdominal tissue can make even 600 to 1,000 cc implants appear lost, so an attractive contour may be impossible. Stable weight matters; fat transfer augmentation is described for patients with stable weight and localized fat. Implant placement, incision and expected shape still depend on your tissues. Extreme caution is advised for these high-risk individuals, and implant choice should follow tissue limits and realistic expectations. A qualified surgeon will discuss these limits with you.

Poor candidates include people whose co-morbidities increase complication risk. Diabetes is linked to impaired wound healing. In breast reconstruction studies, diabetes was not an absolute contraindication to autologous or implant-based reconstruction, but diabetic patients had greater risk of deep incisional surgical-site infection and longer hospital stay; insulin-dependent type 1 diabetes showed a greater effect than type 2 in one very large study. These studies are retrospective and may have selection bias. Evidence here comes mainly from breast reconstruction, not augmentation-specific trials, so your surgeon must carefully judge your individual risk. Good, stable glucose control before and after surgery matters, and specialist input from your physician or diabetes specialist may be needed perioperatively.

Autoimmune conditions such as lupus, rheumatoid arthritis and scleroderma can affect blood flow at both larger and smaller vessel levels, contributing to delayed wound healing, infection, flap or tissue loss. These conditions and their treatments must be considered when choosing the operation and included in the preoperative plan. Current data do not support a link between silicone-filled breast implants and collagen disease, yet the source author is extremely reluctant to place implants in women with autoimmune disease, scleroderma or polyarthritis symptoms. The extent of systemic disease must be evaluated and potential risks explained before deciding whether surgery should be planned.

Your surgeon will examine your breasts and take measurements, then discuss implant shapes, possible sizes, and pocket position behind your breast tissue. Implants may be saline or silicone, placed behind breast tissue, muscle, or fascia, with incisions around the areola, inframammary fold, or armpit depending on anatomy and preference. Fat transfer may suit stable-weight patients with donor fat. Review breast health, asymmetry, weight history, and whether shape, size, or both bother you. Preoperative mammography may be recommended if you are over 35 or have significant breast cancer risk factors. The consultation should also clarify implant fill and surface for your anatomy.